Explanation – Central Serous Retinopathy (aka CSR) is a recurrent retinal condition where a pocket of fluid develops between the layers of the retina. It commonly affects men from 25-45 years of age, with decreasing incidence as we get older. When the macula becomes involved, patients usually notice the dramatic change in vision, loss of color perception and formation of a scotoma, or blind spot. Central Serous Retinopathy is usually recurrent, but is believed not to always involve the macula. Depending upon the location of the involvement, patients may be asymptomatic. Most cases resolve completely within six months of initial symptoms. There are no medicines to prescribe or activities to avoid. Rarely, there may be a small permanent change in vision.
Central Serous Retinopathy
Ophthalmic Management – Initially, there is a long period of observation. Care should be made to reinforce that the condition should NOT worsen over the observation time, although symptoms may not improve. Rarely, a few conditions may mimic CSR such as retinal inflammation or choroidal neovascularization. A fluorescein angiogram can often confirm the diagnosis. On occasion, if a faster recovery is needed, certain cases are amenable to laser treatment. Patients with an identified “hot spot” via fluorescein angiography may be treatable
Summary – Central Serous Retinapathy is a recurrent, usually self-limited, condition that often affects the macula. Symptoms include decreased vision, loss of color perception and development of a grey spot. Usually no treatment is necessary.